VANDA PHARMACEUTICALS
Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs. The company has assembled an experienced team along with a portfolio of clinical and commercial stage programs with the goal of bringing important new treatment options to patients.
VANDA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care
Founded:
2003-01-01
Address:
Washington, District Of Columbia, United States
Country:
United States
Website Url:
http://www.vandapharma.com
Total Employee:
51+
Status:
Active
Contact:
3012941900
Email Addresses:
[email protected]
Total Funding:
72.5 M USD
Technology used in webpage:
Content Delivery Network Domain Not Resolving IPv6 Cloudflare JS CDN JS YouTube Amazon Route 53 Amazon CloudFront FLoC Opt-Out FLoC
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Prospect Venture Partners
Prospect Venture Partners investment in Series B - Vanda Pharmaceuticals
Domain Associates
Domain Associates investment in Series B - Vanda Pharmaceuticals
Official Site Inspections
http://www.vandapharma.com Semrush global rank: 1.07 M Semrush visits lastest month: 31.14 K
- Host name: ec2-107-23-10-234.compute-1.amazonaws.com
- IP address: 107.23.10.234
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Vanda Pharmaceuticals" on Search Engine
Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical Company
Products. See our latest innovations, and where they are in the development process. Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.See details»
Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical Company
Vanda is a leading global biopharmaceutical company. Vanda is developing important new medicines to improve the lives of patients. We use new technologies, including genetics and genomics, to inform our drug discovery, our clinical trials, and our commercial positioning of our compounds.See details»
Vanda Pharmaceuticals - Crunchbase Company Profile & Funding
About. Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies. Washington, District of Columbia, United States. 251-500. Post-IPO Equity. Public. www.vandapharma.com. 26,243. Highlights. Stock Symbol NASDAQ:VNDA. Total Funding Amount. Unlock for free. Contacts 258. …See details»
Vanda Corporate Presentation - September 2023 v1
Vanda Pharmaceuticals Inc. (VNDA) Vanda is a leading global biopharmaceutical company dedicated to innovating in the service of people’s pursuit of happiness. Commercialized. Robust pipeline Products. Upcoming regulatory submissions. HETLIOZ® HETLIOZ LQ®. Fanapt®. Multiple products across wide range of therapeutic areas. …See details»
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year …
Feb 7, 2024 Vanda Pharmaceuticals Inc. Feb 07, 2024, 16:02 ET. Share this article. Full year 2023 revenues were $192.6 million. PONVORY® acquisition completed in Q4 2023 and transition ongoing. 3 FDA PDUFA...See details»
Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical Company
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.See details»
Vanda Pharmaceuticals Inc. (VNDA) - Yahoo Finance Canada
Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia. Corporate Governance. Vanda Pharmaceuticals Inc.’s ISS Governance...See details»
Vanda Pharmaceuticals Inc. (VNDA) - Yahoo Finance
Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia. www.vandapharma.com. 203. Full Time Employees. December 31. Fiscal Year Ends....See details»
Vanda Pharmaceuticals Company Profile - Craft
2024-05-03. Market Capitalization. $284 M. 2024-05-03. Revenue. $192.6 M. FY, 2023. Company Summary. Overview. Vanda Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.See details»
Vanda Pharmaceuticals Inc. | A Global Biopharmaceutical Company
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.See details»
Vanda Pharmaceuticals Reports First Quarter 2024 Financial …
PR Newswire. Wed, May 8, 2024, 4:01 PM 16 min read. In this article: VNDA. Revenues for Q1 2024 were $47.5 million, an increase of 5% compared to Q4 2023. Cash increase of $5.9 million in Q1 2024...See details»
vnda-20201231 - SEC.gov
Dec 31, 2020 Vanda Pharmaceuticals Inc. (we, our, the Company or Vanda) is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients.See details»
Vanda Pharmaceuticals Reports First Quarter 2024 Financial
6 days ago Vanda has scheduled a conference call for today, Wednesday, May 8, 2024, at 4:30 PM ET. During the call, Vanda's management will discuss the first quarter 2024 financial results and other corporate activities. Investors can call 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode number 2594340.See details»
Vanda Pharmaceuticals Reports First Quarter 2024 Financial …
May 8, 2024 Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024. Revenues for Q1 2024 were $47.5 million, an increase of 5% compared to Q4 2023 Cash increase of $5.9 million ...See details»
Vanda Pharmaceuticals Annual Report 2023
Vanda Pharmaceuticals Annual Report 2023 Form 10-K (NASDAQ:VNDA) Published: February 9th, 2023 PDF generated by stocklight.comSee details»
Vanda Pharmaceuticals - Funding, Financials, Valuation & Investors
$72.5M. in funding over 2 rounds. Their latest funding was raised on Oct 29, 2014 from a Post-IPO Equity round. Vanda Pharmaceuticals is registered under the ticker NASDAQ:VNDA . Their stock opened with $10.00 in its Apr 12, 2006 IPO. Vanda Pharmaceuticals is funded by 2 investors.See details»
Despite 80% to 92% premium, Vanda rejects hostile takeover bid
Apr 18, 2024 Two weeks after gaining a hard-earned FDA label expansion for its long-established antipsychotic drug Fanapt (iloperidone), Vanda Pharmaceuticals has derailed a hostile takeover bid. | Two...See details»
Vanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call …
6 days ago Vanda Pharmaceuticals Inc ( NASDAQ:VNDA) is planning to submit a New Drug Application for milsaperidone, which could extend patent exclusivity into the 2040s. The company is developing long-acting ...See details»
Vanda Pharmaceuticals - Contacts, Employees, Board Members, …
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies.See details»
Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline …
Feb 7, 2024 Vanda Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of novel therapies for high unmet medical needs. The company's portfolio includes...See details»